EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation-Reference-Cited by-同舟云学术

EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation

Published:2024-03-23 Issue:7 Volume:59 Page:974-982
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Tolosa-Ridao Carles^ORCID,Cascos Enric,Rodríguez-Lobato Luis Gerardo^ORCID,Pedraza Alexandra,Suárez-Lledó María,Charry Paola^ORCID,Solano María Teresa,Martinez-Sanchez Julia,Cid Joan^ORCID,Lozano Miquel^ORCID,Rosiñol Laura^ORCID,Esteve Jordi^ORCID,Urbano-Ispizua Álvaro,Fernández-Avilés Francesc,Martínez Carmen^ORCID,Carreras Enric,Díaz-Ricart Maribel^ORCID,Rovira Montserrat,Salas María Queralt^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41409-024-02270-x.pdf

Reference41 articles.

1. Snowden JA, Sánchez-Ortega I, Corbacioglu S, Basak GW, Chabannon C, de la Camara R, et al. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transpl. 2022;57:1217–39.

2. Kanate AS, Majhail N, DeFilipp Z, Dhakal B, Dholaria B, Hamilton B, et al. Updated indications for immune effector cell therapy: 2023 guidelines from the American Society for Transplantation and cellular therapy. Transpl Cell Ther. 2023;29:594–7.

3. McDonald GB, Sandmaier BM, Mielcarek M, Sorror M, Pergam SA, Cheng GS, et al. Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003–2007 versus 2013–2017 cohorts. Ann Intern Med. 2020;172:229–39.

4. Passweg JR, Baldomero H, Chabannon C, Basak GW, de la Cámara R, Corbacioglu S, et al. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transpl. 2021;56:1651–64.

5. Penack O, Peczynski C, Mohty M, Yakoub-Agha I, Styczynski J, Montoto S, et al. How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT. Blood Adv. 2020;4:6283–90.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC;Bone Marrow Transplantation;2024-09-14

2. Cardiac Events Occurring after Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide. Study Conducted on Behalf of the GETH-TC;2024-07-26